- Home
- LPCN vs GNLN Comparison
LPCN vs GNLN Comparison
Compare LPCN & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- GNLN
- Stock Information
- Founded
- LPCN 1997
- GNLN 2005
- Country
- LPCN United States
- GNLN United States
- Employees
- LPCN N/A
- GNLN N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- GNLN Durable Goods
- Sector
- LPCN Health Care
- GNLN Consumer Discretionary
- Exchange
- LPCN Nasdaq
- GNLN Nasdaq
- Market Cap
- LPCN 16.1M
- GNLN 12.9M
- IPO Year
- LPCN N/A
- GNLN 2019
- Fundamental
- Price
- LPCN $2.99
- GNLN $3.70
- Analyst Decision
- LPCN Strong Buy
- GNLN
- Analyst Count
- LPCN 2
- GNLN 0
- Target Price
- LPCN $9.00
- GNLN N/A
- AVG Volume (30 Days)
- LPCN 16.6K
- GNLN 88.9K
- Earning Date
- LPCN 11-06-2025
- GNLN 11-14-2025
- Dividend Yield
- LPCN N/A
- GNLN N/A
- EPS Growth
- LPCN N/A
- GNLN N/A
- EPS
- LPCN N/A
- GNLN N/A
- Revenue
- LPCN $4,208,119.00
- GNLN $7,954,000.00
- Revenue This Year
- LPCN N/A
- GNLN $1,541.21
- Revenue Next Year
- LPCN N/A
- GNLN N/A
- P/E Ratio
- LPCN N/A
- GNLN N/A
- Revenue Growth
- LPCN N/A
- GNLN N/A
- 52 Week Low
- LPCN $2.68
- GNLN $2.84
- 52 Week High
- LPCN $6.17
- GNLN $5,130.00
- Technical
- Relative Strength Index (RSI)
- LPCN 50.61
- GNLN 51.35
- Support Level
- LPCN $2.85
- GNLN $3.35
- Resistance Level
- LPCN $3.08
- GNLN $3.74
- Average True Range (ATR)
- LPCN 0.09
- GNLN 0.24
- MACD
- LPCN 0.01
- GNLN 0.10
- Stochastic Oscillator
- LPCN 59.83
- GNLN 73.33
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.